Literature DB >> 15205123

White matter lesions in panencephalopathic type of Creutzfeldt-Jakob disease: MR imaging and pathologic correlations.

Eiji Matsusue1, Toshibumi Kinoshita, Shuji Sugihara, Shinya Fujii, Toshihide Ogawa, Eisaku Ohama.   

Abstract

BACKGROUND AND
PURPOSE: A panencephalopathic type of Creutzfeldt-Jakob disease (pCJD) is characterized by the extensive involvement of the cerebral white matter as well as the cerebral gray matter. It has been a point of controversy, however, whether the white matter changes represent primary or secondary degeneration. The aim of this study was to elucidate, by using MR images and histologic examinations, whether the white matter lesions in pCJD are primary or secondary degeneration.
METHODS: Serial changes of T2 hyperintensities and histologic findings of six autopsy-proved cases of pCJD were retrospectively analyzed.
RESULTS: Serial MR images of brains affected by pCJD revealed that T2 hyperintensities appeared in the cerebral gray matter 2-5 months after onset and in the cerebral white matter around the lateral ventricles approximately 5 months after onset. They rapidly extended to deep and subcortical white matter during the next several months and then to the entire cerebral white matter 10 months after onset. Histologic examination of the white matter lesions revealed spongy changes or tissue rarefaction associated with gemistocytic astrocytosis, which indicates primary involvement of the white matter. At the terminal stages of cases with a longer clinical course, MR images showed T2 hyperintensities in the corticospinal tracts in the internal capsule and brain stem, which histologically disclosed loss of myelin and axons accompanied by fibrillary gliosis that indicates secondary degeneration.
CONCLUSION: Cerebral white matter lesions in pCJD were considered to be primary changes of the disease, but the lesions of the corticospinal tracts were secondary to cortical or cerebral or both white matter lesions.

Entities:  

Mesh:

Year:  2004        PMID: 15205123      PMCID: PMC7975660     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  28 in total

1.  [T2-weighted MRI and pathological findings in the cerebral hemisphere of panencephalitic Creutzfeldt-Jakob disease].

Authors:  M Konagaya; M Sakai; K Asakura; Y Matsuoka; Y Hashizume
Journal:  No To Shinkei       Date:  2001-04

2.  Diffusion-weighted magnetic resonance imaging in Creutzfeldt-Jakob disease.

Authors:  P Demaerel; A L Baert; L Vanopdenbosch; W Robberecht; R Dom
Journal:  Lancet       Date:  1997-03-22       Impact factor: 79.321

3.  Magnetic resonance imaging in the clinical diagnosis of Creutzfeldt-Jakob disease.

Authors:  A Schröter; I Zerr; K Henkel; H J Tschampa; M Finkenstaedt; S Poser
Journal:  Arch Neurol       Date:  2000-12

4.  Panencephalopathic type of Creutzfeldt-Jakob disease with primary extensive involvement of white matter.

Authors:  H Krüger; C Meesmann; E Rohrbach; J Müller; H G Mertens
Journal:  Eur Neurol       Date:  1990       Impact factor: 1.710

5.  On the white matter lesions of the Creutzfeldt-Jakob disease. Can a new subentity be recognized in man?

Authors:  G Macchi; A L Abbamondi; G di Trapani; A Sbriccoli
Journal:  J Neurol Sci       Date:  1984-02       Impact factor: 3.181

Review 6.  Subacute spongiform virus encephalopathies. Scrapie, Kuru and Creutzfeldt-Jakob disease: a review.

Authors:  P W Lampert; D C Gajdusek; C J Gibbs
Journal:  Am J Pathol       Date:  1972-09       Impact factor: 4.307

7.  Transmission of chronic spongiform encephalopathy with kuru plaques from humans to small rodents.

Authors:  J Tateishi; M Ohta; M Koga; Y Sato; Y Kuroiwa
Journal:  Ann Neurol       Date:  1979-06       Impact factor: 10.422

8.  Cerebral MR and CT imaging in Creutzfeldt-Jakob disease.

Authors:  J Kovanen; T Erkinjuntti; M Iivanainen; L Ketonen; M Haltia; R Sulkava; J T Sipponen
Journal:  J Comput Assist Tomogr       Date:  1985 Jan-Feb       Impact factor: 1.826

9.  [An autopsy case of panencephalopathic type of Creutzfeldt-Jakob disease: an early clinical sign documented by magnetic resonance imaging].

Authors:  R Okiyama; K Tsuchiya; T Furukawa; H Tsukagoshi; K Kosaka
Journal:  Rinsho Shinkeigaku       Date:  1989-08

10.  [Computed tomography of Creutzfeldt-Jakob disease].

Authors:  A Yagishita
Journal:  Rinsho Hoshasen       Date:  1989-10
View more
  10 in total

1.  Diffusion-weighted and fluid-attenuated inversion recovery imaging in Creutzfeldt-Jakob disease: high sensitivity and specificity for diagnosis.

Authors:  Geoffrey S Young; Michael D Geschwind; Nancy J Fischbein; Jennifer L Martindale; Roland G Henry; Songling Liu; Ying Lu; Stephen Wong; Hong Liu; Bruce L Miller; William P Dillon
Journal:  AJNR Am J Neuroradiol       Date:  2005 Jun-Jul       Impact factor: 3.825

2.  Diffusion-weighted imaging and magnetic resonance spectroscopy of sporadic Creutzfeldt-Jakob disease: correlation with clinical course.

Authors:  Jae Hyoung Kim; Byung Se Choi; Cheolkyu Jung; YoungHee Chang; SangYun Kim
Journal:  Neuroradiology       Date:  2011-01-11       Impact factor: 2.804

3.  Diffusion-weighted MRI findings and clinical correlations in sporadic Creutzfeldt-Jakob disease.

Authors:  Ting Gao; Jin-Hao Lyu; Jia-Tang Zhang; Xin Lou; Wei Zhao; Xiao-Wei Xing; Ming Yang; Yan Yao; Qing-Che Tan; Cheng-Lin Tian; Xu-Sheng Huang; Lin Ma; Sheng-Yuan Yu
Journal:  J Neurol       Date:  2015-04-11       Impact factor: 4.849

Review 4.  Radiological assessment of Creutzfeldt-Jakob disease.

Authors:  Henriette J Tschampa; Inga Zerr; Horst Urbach
Journal:  Eur Radiol       Date:  2006-11-09       Impact factor: 5.315

Review 5.  Rapidly progressive dementia.

Authors:  Michael D Geschwind; Huidy Shu; Aissa Haman; James J Sejvar; Bruce L Miller
Journal:  Ann Neurol       Date:  2008-07       Impact factor: 10.422

6.  Cerebral white matter disruption in Creutzfeldt-Jakob disease.

Authors:  H Lee; O S Cohen; H Rosenmann; C Hoffmann; P B Kingsley; A D Korczyn; J Chapman; I Prohovnik
Journal:  AJNR Am J Neuroradiol       Date:  2012-05-10       Impact factor: 3.825

7.  Cerebral cortical and white matter lesions in amyotrophic lateral sclerosis with dementia: correlation with MR and pathologic examinations.

Authors:  E Matsusue; S Sugihara; S Fujii; T Kinoshita; T Nakano; E Ohama; T Ogawa
Journal:  AJNR Am J Neuroradiol       Date:  2007-09       Impact factor: 3.825

8.  White matter involvement in sporadic Creutzfeldt-Jakob disease.

Authors:  Eduardo Caverzasi; Maria Luisa Mandelli; Stephen J DeArmond; Christopher P Hess; Paolo Vitali; Nico Papinutto; Abby Oehler; Bruce L Miller; Irina V Lobach; Stefano Bastianello; Michael D Geschwind; Roland G Henry
Journal:  Brain       Date:  2014-11-02       Impact factor: 13.501

9.  White Matter Integrity Involvement in the Preclinical Stage of Familial Creutzfeldt-Jakob Disease: A Diffusion Tensor Imaging Study.

Authors:  Donglai Jing; Yaojing Chen; Kexin Xie; Yue Cui; Chunlei Cui; Li Liu; Hui Lu; Jing Ye; Ran Gao; Lin Wang; Zhigang Liang; Zhanjun Zhang; Liyong Wu
Journal:  Front Aging Neurosci       Date:  2021-05-19       Impact factor: 5.750

10.  Differential astrocyte and oligodendrocyte vulnerability in murine Creutzfeldt-Jakob disease.

Authors:  Pol Andrés-Benito; Margarita Carmona; Jean Yves Douet; Hervé Cassard; Olivier Andreoletti; Isidro Ferrer
Journal:  Prion       Date:  2021-12       Impact factor: 3.931

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.